Eckler, JR; Chang-Fong, J; Rabin, RA; Smith, C; Teitler, M; Glennon, RA; Winter, JC. Behavioral characterization of 2-O-desmethyl and 5-O-desmethyl metabolites of the phenylethylamine hallucinogen DOM. Pharmacol. Biochem. Behav., 1 Jan 2003, 75 (4), 845–852. 294 kB. https://doi.org/10.1016/S0091-3057(03)00159-X
Lyon, RA; Titeler, M; Seggel, MR; Glennon, RA. Indolealkylamine analogs share 5-HT2 binding characteristics with phenylalkylamine hallucinogens. Eur. J. Pharmacol., 19 Jan 1988, 145 (3), 291–297. 533 kB. https://doi.org/10.1016/0014-2999(88)90432-3
Eckler, JR. Stimulus control by hallucinogens: SSRI interactions. Ph. D. Thesis, State University of New York, Buffalo, NY, USA, 20 Dec 2002. 2.9 MB.
McCorvy, JD. Mapping the binding site of the 5-HT2A receptor using mutagenesis and ligand libraries: Insights into the molecular actions of psychedelics. Ph. D. Thesis, Purdue University, 1 Jan 2012. 3.9 MB. #5-OH DOM